Benitec Biopharma (BNTC) Shares Outstanding (2019 - 2025)

Benitec Biopharma has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $46.0 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 96.02% year-over-year to $46.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $46.0 million (up 96.02% YoY) and the FY2025 annual result came in at $36.2 million, up 791.81% from the prior year.
• Shares Outstanding (Entity) climbed to $46.0 million in Q4 2025 per BNTC's latest filing, from $41.5 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $46.0 million in Q4 2025 and troughed at $252656.0 in Q2 2021.
• A 5-year average of $10.8 million and a median of $2.1 million in 2022 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) surged 32.85% in 2022, then surged 1316.6% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $480659.0 in 2021, then jumped by 242.42% to $1.6 million in 2022, then jumped by 57.51% to $2.6 million in 2023, then soared by 804.61% to $23.5 million in 2024, then jumped by 96.02% to $46.0 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $46.0 million, $41.5 million, and $36.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.